1378388-35-2 Usage
General Description
The chemical (3S,5S)-1-(tert-butoxycarbonyl)-5-(methoxycarbonyl)pyrrolidine-3-carboxylic acid is a compound with the molecular formula C14H23NO6. (3S,5S)-1-(tert-butoxy
carbonyl)-5-(methoxy
carbonyl)pyrrolidine-3
-carboxylic acid is a derivative of pyrrolidine-3-carboxylic acid, with tert-butoxycarbonyl and methoxycarbonyl groups attached to the 1 and 5 positions, respectively. It is commonly used as a building block in organic synthesis and as a protecting group for amines and carboxylic acids. (3S,5S)-1-(tert-butoxy
carbonyl)-5-(methoxy
carbonyl)pyrrolidine-3
-carboxylic acid has potential applications in the pharmaceutical and chemical industries, particularly in the synthesis of peptides and other complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 1378388-35-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,8,3,8 and 8 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1378388-35:
(9*1)+(8*3)+(7*7)+(6*8)+(5*3)+(4*8)+(3*8)+(2*3)+(1*5)=212
212 % 10 = 2
So 1378388-35-2 is a valid CAS Registry Number.
1378388-35-2Relevant articles and documents
Compound used for inhibiting hepatitis C virus, and pharmaceutical applications thereof
-
Paragraph 0018; 0021, (2018/04/01)
The invention relates to a compound which is represented by formula I, is used for inhibiting hepatitis C virus, and possesses excellent bioavailability, and a nontoxic pharmaceutically acceptable salt thereof. The compound possesses extremely high inhibition effect on HCV of all genotypes. In the formula I, R is used for representing hydrogen atom, glycyl, L-alanyl, L-leucyl, L-valyl, or L-isoleucyl.
ANTIVIRAL COMPOUNDS
-
Paragraph 0320; 0322, (2015/12/31)
The disclosure is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.
ANTIVIRAL COMPOUNDS
-
Paragraph 0258, (2014/07/08)
The disclosure is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.